Etoposide/carboplatin chemotherapy for the treatment of metastatic myxomatous cerebral aneurysms by Branscheidt, Meret et al.
LETTER TO THE EDITORS
Etoposide/carboplatin chemotherapy for the treatment
of metastatic myxomatous cerebral aneurysms
Meret Branscheidt • Karl Frontzek •
Oliver Bozinov • Anton Valavanis • Elisabeth J. Rushing •
Michael Weller • Susanne Wegener
Received: 9 January 2014 / Accepted: 8 February 2014 / Published online: 7 March 2014
 Springer-Verlag Berlin Heidelberg 2014
Dear Sirs,
Myxomas comprise the majority of cardiac tumors [1].
Patients may experience signs of cardiac obstruction or
systemic embolism, accompanied by non-specific systemic
symptoms such as fever or malaise [2]. Embolization to the
central nervous system is common. However, while
embolic stroke due to cardiac myxoma is treated by tumor
resection, delayed neurological complications may arise
from metastatic spread of myxomatous cells into the brain,
causing either aneurysms or solid tumor growth. In these
rare cases, the clinical course is often complicated and an
effective therapeutic regimen has not yet been established
(Online Resource 1) [3–10].
A 41-year-old female patient was referred following a
brain magnetic resonance imaging (MRI) scan for the
diagnostic work-up of new-onset ‘‘burning’’ headaches and
increasing fatigue. MRI showed multiple acute and suba-
cute T2-hyperintensities, suggesting a proximal embolic
source or possibly vasculitis (Online Resource 1). Routine
blood results, spinal fluid analysis, and conventional
angiography were unremarkable. Transesophageal echo-
cardiography (TEE) revealed a 5.2 9 2.6 mm left atrial
tumor. The tumor was resected, and histologic examination
confirmed the diagnosis of a cardiac myxoma (Fig. 1a, b).
After an uneventful postoperative period, the patient
reported the new onset of pounding headaches about one
year later. Follow-up MRI demonstrated the presence of
microbleeds and multiple fusiform aneurysms (Fig. 2a).
TEE was repeated, but no recurrence of the cardiac myx-
oma was found. At the same time, the patient suffered from
recurrent simple focal seizures and a mild sensorimotor
paralysis of the left arm. Angiography now revealed the
presence of multiple fusiform aneurysms (Fig. 2g). Biopsy
of the largest aneurysm in the right pre-central region
demonstrated intramural and intravascular collections of
neoplastic spindle cells embedded in myxoid material,
along with blood extravasation and perivascular lympho-
plasmacytic infiltrates consistent with metastatic emboli of
the previously resected ([ 1year before) cardiac myxoma
(Fig. 1c). Five months later, the patient reported progres-
sive loss of function of the left hand and severe burning
headaches. Follow-up MRI demonstrated a dramatic pro-
gression of the aneurysms and hemorrhages (Fig. 2b). 18F-
Ethyltyrosine (FET)-PET showed metabolic activity within
the largest aneurysm, suggestive of a neoplastic focus
(Fig. 2h). At this time, combined chemotherapy with eto-
poside (100 mg/m2 body surface area, days 2 and 3) and
carboplatin (240 mg/m2 body surface area, day 1),
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administered over a three-day period, in addition to 4 mg/d
dexamethasone was started. After two cycles, the patient
showed major clinical improvement. MRI confirmed a
reduction in hematoma volumes and brain edema, and
stable aneurysm size (Fig. 2c). However, two months after
conclusion of six cycles of etoposide/carboplatin, admin-
istered in 4-week intervals, a control MRI again revealed
increased size and contrast enhancement as well as edema
progression of the largest right pre-central aneurysmatic
lesion (Fig. 2d). To prevent further damage from bleeding
and pressure effects, this lesion was surgically resected
(Fig. 2e). The resected tissue specimen revealed ongoing
myxoma invasion and an even more pronounced inflam-
matory reaction (Fig. 1d–g). Therefore, three weeks after
surgery, the patient was started on immunosuppressive and
anti-inflammatory therapy with i.v. cyclophosphamide
(600 mg/m2 body surface area). She has received four
cycles so far, and remains clinically stable on 1.5 mg
dexamethasone, which will be slowly tapered off. Recent
angiography and MRI have confirmed stable aneurysm size
and distribution (Fig. 2f, j).
In cases of severe neurological impairment due to
multifocal myxomatous aneurysms, where a wait-and-see
strategy is not a reasonable therapeutic option, chemo-
therapy may stabilize disease progression. Longer follow-
up is needed to evaluate whether disease control with the
cyclophosphamide regimen proves superior to other
agents.
Fig. 1 Histological analysis of cardiac tumor and cerebral aneurysms
a The papillary aortic tumor is dominated by a paucicellular myxoid
background. b In addition to the stellate tumor cells, scattered plasma
cells and lymphocytes are embedded in the myxoid stroma.
c Although more cellular, the first brain metastasis demonstrates the
unmistakable histological features of myxoma. A mitotic figure is
present (arrowhead). d, e Microscopic examination of the second
brain sample reveals a large, aneurysmal dilatation of the sampled
artery, with intramural and intraluminal infiltrates of small, bland,
spindled tumor cells embedded in a myxoid matrix (arrowheads).
Dense chronic inflammation is seen surrounding the vessel, and
scattered inflammatory cells are found within the myxoma (arrows in
e). f The Elastica-von-Gieson stain shows disruption of the internal
elastic lamina (arrowheads) at the base of the aneurysm. g Higher
magnification shows sparse mitotic activity of the tumor cells
(arrowhead). a, e hematoxylin-eosin, scale bar = 200 lm. b hema-
toxylin-eosin, scale bar = 100 lm. c, g hematoxylin-eosin, scale bar =
50 lm. d hematoxylin-eosin, scale bar = 1 mm. f Elastica-von-
Gieson, scale bar = 1 mm
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Fig. 2 Myxomatous aneurysms in the brain: multimodal imaging. a–
f T2-(upper panel) and T1-weighted, contrast-enhanced images
(lower panel) demonstrating the growth of the aneurysms as well as
extension of hemorrhage and edema before a, b and after c, d,
e chemotherapy with etoposide/carboplatin and cyclophosphamide f,
which was started in 09/2013. In August 2013 (between d and e), the
large aneurysm on the right pre-central region was surgically
removed. g: Conventional angiography from 8/12 with multiple
fusiform aneurysms (red arrow), some still detectable after etoposide/
carboplatin chemotherapy in 8/13 i. j, h: FET-PET maps of a slice
corresponding to the images above before j and after h etoposide/
carboplatin chemotherapy. FET accumulation is not significantly
reduced after treatment.
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